Cwm, LLC Agenus Inc Transaction History

Cwm, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	SELL	$0.45 - $17.57 $102 - $4,005	-228 Reduced 29.08%	556 $9,000
Q1 2024 Apr 05, 2024	BUY	$0.53 - $0.93 $393 - $690	743 Added 1812.2%	784 $0
Q4 2023 Feb 01, 2024	BUY	$0.63 - $1.14 $25 - $46	41 New	41 $0
Q2 2023 Aug 03, 2023	BUY	$1.31 - $2.04 $37 - $59	29 Added 34.94%	112 $0
Q1 2023 Apr 28, 2023	SELL	$1.45 - $2.95 $484 - $985	-334 Reduced 80.1%	83 $0
Q4 2022 Feb 01, 2023	BUY	$2.02 - $3.25 $842 - $1,355	417 New	417 $1,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.